Graypoint LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $635K | Sell |
13,721
-5,700
| -29% | -$264K | 0.04% | 287 |
|
|
2025
Q1 | $1.18M | Buy |
19,421
+3,423
| +21% | +$209K | 0.07% | 175 |
|
|
2024
Q4 | $905K | Buy |
15,998
+4,705
| +42% | +$266K | 0.05% | 207 |
|
|
2024
Q3 | $584K | Buy |
11,293
+2,563
| +29% | +$133K | 0.04% | 271 |
|
|
2024
Q2 | $363K | Sell |
8,730
-4,912
| -36% | -$204K | 0.03% | 346 |
|
|
2024
Q1 | $740K | Sell |
13,642
-133
| -1% | -$7.21K | 0.05% | 217 |
|
|
2023
Q4 | $707K | Buy |
13,775
+1,848
| +15% | +$94.8K | 0.06% | 205 |
|
|
2023
Q3 | $692K | Buy |
11,927
+2,767
| +30% | +$161K | 0.07% | 192 |
|
|
2023
Q2 | $586K | Sell |
9,160
-2,161
| -19% | -$138K | 0.06% | 195 |
|
|
2023
Q1 | $785K | Buy |
11,321
+3
| +0% | +$208 | 0.09% | 154 |
|
|
2022
Q4 | $814K | Sell |
11,318
-1,625
| -13% | -$117K | 0.1% | 141 |
|
|
2022
Q3 | $920K | Buy |
12,943
+4,511
| +53% | +$321K | 0.12% | 128 |
|
|
2022
Q2 | $649K | Buy |
8,432
+581
| +7% | +$44.7K | 0.08% | 159 |
|
|
2022
Q1 | $573K | Buy |
7,851
+63
| +0.8% | +$4.6K | 0.06% | 189 |
|
|
2021
Q4 | $486K | Sell |
7,788
-124
| -2% | -$7.74K | 0.05% | 201 |
|
|
2021
Q3 | $468K | Sell |
7,912
-1,286
| -14% | -$76.1K | 0.06% | 173 |
|
|
2021
Q2 | $615K | Buy |
9,198
+776
| +9% | +$51.9K | 0.08% | 149 |
|
|
2021
Q1 | $532K | Buy |
8,422
+560
| +7% | +$35.4K | 0.08% | 156 |
|
|
2020
Q4 | $488K | Buy |
7,862
+280
| +4% | +$17.4K | 0.08% | 145 |
|
|
2020
Q3 | $457K | Buy |
7,582
+2,666
| +54% | +$161K | 0.09% | 137 |
|
|
2020
Q2 | $289K | Buy |
4,916
+25
| +0.5% | +$1.47K | 0.07% | 134 |
|
|
2020
Q1 | $272K | Buy |
+4,891
| New | +$272K | 0.08% | 126 |
|